We are delighted to announce that UK DRI Group Leader Dr Mootaz Salman has been awarded the Bayliss-Starling Prize Lecture 2025 by The Physiological Society. This prestigious mid-career prize lecture recognises outstanding contributions to physiology and was delivered at the IUPS 2025 meeting in Frankfurt, Germany, 11–14 September 2025. He will also deliver the Bayliss-Starling Lecture at the Society’s annual meeting.
Dr Salman is a Group Leader at the BHF-UK DRI Centre for Vascular Dementia Research (CVDR) and the Oxford Centre for Research Excellence (CRE), as well as Group Leader at the Kavli Institute for Nanoscience Discovery. His research focuses on developing human iPSC-derived models, including blood–brain barrier-on-a-chip and brain organoid systems, to investigate neurovascular function, inflammation, and mechanisms of neurodegenerative disease.
I was truly honoured to deliver the Bayliss-Starling Prize Lecture at IUPS in Frankfurt. It was a wonderful experience to share our work on the blood–brain barrier with an inspiring international community, and to celebrate this recognition made possible by the collaborative and supportive environments at DPAG, the Kavli Institute, Oxford CRE, and the BHF-UK DRI CVDR.
Group Leader
The Bayliss-Starling Prize Lecture for Mid-Career Physiologists is an annual lecture was established in 1960 as a joint memorial to Bayliss and Starling. It is awarded to a mid-career physiologist to celebrate a discreet package of work that has made a significant impact on physiological understanding.
The award highlights Dr Salman’s pioneering work at the interface of neuroscience, physiology, and bioengineering, and his commitment to advancing translational approaches that bridge fundamental discovery with therapeutic innovation.
Salman Lab
Explore the work of the Salman Lab focused on understanding the role of the blood-brain barrier in neurodegeneration.
